Astellas shedding 600-plus jobs as CEO shakes up R&D and sales ops in restructuring
As Astellas president and CEO Kenji Yasukawa maps out a strategic plan for the company he’s just recently taken over, he’s also prescribed a round of restructuring with a goal to cut at least 600 employees through an early retirement scheme.
The Japanese company is looking at an overhaul in R&D and sales and marketing as well as restructuring its group companies in Japan. That means shutting down Astellas Research Technologies, Astellas Marketing and Sales Support, and Astellas Learning Institute. It’s also planning to divest Astellas Analytical Science Laboratories to Eurofins Pharma Services by the end of this fiscal year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.